NK cell therapies are moving closer to routine clinical use, but logistics remain an underestimated variable. Comparative data suggest cryopreservation can reduce viability and functional cytotoxicity compared to controlled live transport conditions, highlighting how handling can directly influence therapeutic cell quality.